Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Anticipated CAGR of the Liver Diseases Therapeutics Market, and What Factors Will Drive It?

In recent years, there has been significant growth in the size of the liver diseases therapeutics market. There is an expected rise from $14.16 billion in 2024 to $15.23 billion in 2025, representing a compound annual growth rate (CAGR) of 7.6%. Several factors contributed to this growth during the historic period including high incidence of liver diseases, patterns of alcohol consumption, advancements in diagnostic procedures, the prevalence of obesity and metabolic syndrome, widespread awareness and screening programs, and governmental measures aimed at controlling hepatitis.

The market size of liver diseases therapeutics is anticipated to witness substantial growth in the upcoming years, with a projected escalation to $20.78 billion in 2029 at a compound annual growth rate of 8.1%. The expected growth during the forecasted period is due to the impact of precision medicine techniques, innovative RNA therapeutic strategies, concentration on fibrosis therapies, patient assistance and advocacy groups, hepatitis vaccines development, and regulatory approval for rare drugs. Notable trends predicted within the forecasted timeline include advancements in hepatitis C treatments, the emergence of innovative therapies for liver fibrosis, the examination of immunotherapies, the introduction of telemedicine and remote monitoring, as well as a focus on nutritional interventions.

What Strategic Factors Are Influencing the Accelerated Growth of the liver diseases therapeutics Market?

The acceleration in liver diseases is expected to boost the liver disease therapeutics market’s growth. Liver disease pertains to any condition disrupting the liver’s functioning. Various therapies are offered by liver disease therapeutics to treat these conditions. For instance, in April 2024, the Office for Health Improvement and Disparities, a government agency in the UK, reported that in 2022, the death rate due to liver disease in individuals under 75 years old in England surged to 21.4 per 100,000 population. Males saw 6,664 premature deaths, while there were 3,929 deaths in females. Consequently, the escalating occurrence of liver diseases stimulates the expansion of the liver disease therapeutics market.

Request Your Free Liver Diseases Therapeutics Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=7969&type=smp

Who Are the Top Companies Contributing to the Growth of the Liver Diseases Therapeutics Market?

Major companies operating in the liver diseases therapeutics market are:

• Astellas Pharma Inc._x000D_

• Bristol-Myers Squibb Company_x000D_

• F. Hoffmann-La Roche AG_x000D_

• Merck & Co. Inc._x000D_

• Novartis AG_x000D_

How Are Technological Trends Affecting the Growth and Development of the Liver Diseases Therapeutics Market?

One notable trend emerging in the liver disease therapeutics market is the formation of strategic partnerships. Leading firms in this market are focusing on collaborations to consolidate their market position. As an example, in January 2022, a collaboration was announced between Aligos Therapeutics Inc., an American clinical-stage biopharmaceutical company, and Merck & Co, another US-based company specializing in liver disease therapeutics. This joint venture is aimed at the discovery and development of oligonucleotide therapies for non-alcoholic steatohepatitis.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Which Segments of the Liver Diseases Therapeutics Market Hold the Most Potential for Future Development?

The liver diseases therapeutics market covered in this report is segmented –

1) By Disease Type: Hepatitis, Non-Alcoholic Fatty Liver Disease, Alcohol-Induced, Liver Cancer

2) By Treatment: Antiviral, Vaccines, Chemotherapy, Immunosuppressive Agents, Corticosteroids

3) By End User: Hospitals, Ambulatory Surgery Centers, Other End Users

Subsegments:

1) By Hepatitis: Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D

2) By Non-Alcoholic Fatty Liver Disease (NAFLD): Non-Alcoholic Steatohepatitis (NASH), Simple Fatty Liver

3) By Alcohol-Induced Liver Disease: Alcoholic Hepatitis, Alcoholic Cirrhosis

4) By Liver Cancer: Hepatocellular Carcinoma (HCC), Cholangiocarcinoma

What Are the Key Regions Powering Growth in the Liver Diseases Therapeutics Market?

North America was the largest region in the liver diseases therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the liver diseases therapeutics market report during the forecast period. The regions covered in the liver diseases therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Defines the Scope of the Liver Diseases Therapeutics Market?

Liver disease therapeutics refers to the treatment of numerous types of liver illnesses, diseases brought on by viruses, including hepatitis A, B, and C. Liver disease therapeutics are essential for enhancing the quality of life for those impacted by liver conditions and alleviating the overall strain of liver disease on healthcare systems.

Browse Through More Similar Reports By The Business Research Company:

Digital Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/digital-therapeutics-global-market-report

Neurodegenerative Disorder Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report

Peptide Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: